Peptides: Swallow Them If You Like. Injecting Them Is a Different Decision Entirely.

You know the moment it starts. You’re in the bathroom looking at your own face closer than is good for anyone, and you notice something that wasn’t there two years ago. Or you get up off the sofa and hear your knee before you feel it. Or you’ve trained consistently for six years and your body has started answering more slowly than it used to.

Then a post appears on your phone. Soft lighting, a frosted glass jar, and a word that sounds like medicine rather than a supplement: peptides.

Peptides for skin. Peptides for joints. Peptides for recovery. Peptides for ageing. And, inevitably, peptides for weight.

Plenty of people have bought them, and there’s nothing embarrassing about that. The word was chosen brilliantly. It sounds like access to real science rather than another tub of powdered botanicals off a high-street shelf — and the reason it sounds that way is that peptide medicine genuinely is real science. Some of the most consequential drugs of the past decade are peptides.

The problem is that the jar and the drug have almost nothing to do with each other, and the gap between them isn’t about the molecule. It’s about who tested it, in what species, and how many of them survived.

What a Peptide Actually Is

Nothing mystical. A peptide is a small protein.

A protein is a chain of amino acids. When the chain is short — roughly under 40 to 50 amino acids — convention calls it a peptide. When it’s long, we call it a protein. The line is about as arbitrary as the one that makes a seventeen-year-old a child and an eighteen-year-old an adult. Same building blocks, different length.

Which means an egg, a tub of cottage cheese, a chicken breast and your expensive jar are all made of the same material. And it means one more thing, which isn’t printed on the label — anything built from amino acids is something your digestive system already knows exactly how to take apart.

The Drugs That Actually Work Are Peptides Too

This is the part usually left out of both sides of the argument, and it matters more than anything else in this article.

Insulin is a peptide. Semaglutide — the active ingredient in Ozempic and Wegovy — is a peptide. Tirzepatide, sold as Mounjaro, is a peptide. So is teriparatide for osteoporosis, so is desmopressin, so are the GnRH analogues used in oncology. These aren’t fringe compounds. They are among the most rigorously studied medicines in circulation.

So nobody sensible argues that peptides don’t do anything. They plainly do. The question worth asking about any specific peptide is much narrower, and it has an answer you can usually look up in an afternoon:

• Has it been given to humans in a controlled trial, or only to animals
• How many humans, and for how long
• Was it published and independently reviewed, or is it a forum post
• Does a regulator — the MHRA here — hold a licence for it
• Is anyone professionally accountable if it harms you

Semaglutide clears all five. It went through phase I, II and III trials involving tens of thousands of people, with cardiovascular outcome data running for years, published in journals anyone can read, reviewed by regulators in multiple countries, and prescribed by clinicians whose registration depends on getting it right. The side effects are documented because somebody counted them.

Now hold the compounds sold in vials on peptide websites against the same five questions. Most of them fail at the first one.

Why Swallowing Peptides Is Mostly Money Spent on Your Digestion

Start with the harmless end of the market, because it deserves less alarm than it usually gets.

Your stomach and small intestine have one very specific job: take anything made of amino acids and cut it into pieces. They have dedicated tools for it — pepsin, trypsin, peptidases lining the gut wall. Those enzymes do not care whether the chain arrived in a sausage or in a jar that cost £90. The chain gets cut into individual amino acids and short fragments, those get absorbed, and your body spends them on whatever it needs at that moment.

Not what you need. Not what the packaging promised.

The peptide sold as “targeted collagen support for skin” does not enter your bloodstream in the shape you paid for. It arrives as glycine, proline, lysine — the same raw material you get from ordinary food. Your body has no mechanism for routing those amino acids specifically to the line on your forehead.

There’s a useful tell here, and checking it is free. In Great Britain a supplement may only carry a health claim that appears on the official GB nutrition and health claims register. No peptide supplement holds an authorised claim for skin, joints or ageing. That’s why the labels talk in atmosphere rather than outcomes — “supports”, “designed for”, “inspired by clinical research”. The vagueness isn’t lazy copywriting. It’s the legal ceiling.

In fairness, there are exceptions worth naming. Certain collagen di- and tripeptides do turn up intact in the bloodstream in human studies, and some trials report small improvements in skin elasticity or joint discomfort. But the effects are modest, the designs are often weak, and a large share of the research is funded by the companies selling the product. It isn’t a miracle. It’s a small, statistically detectable effect priced like one.

So do the maths honestly. A kilo of whey protein runs about £25. A month of anti-ageing peptides runs £40 to £150. Broadly the same stream of amino acids, one of them in frosted glass.

And if you want to buy them anyway, buy them

That is a real position, not a grudging one.

An oral peptide supplement from a reputable UK retailer is, in the overwhelming majority of cases, food. Expensive food. It is unlikely to do what the advertising implies, and it is also unlikely to do anything to you. The realistic worst case is a lighter wallet and a mild sense of having been had.

People take supplements for reasons that aren’t strictly pharmacological — a routine, a sense of having taken action, the small daily signal that they’re looking after themselves. Those reasons are legitimate. If a £40 jar makes someone more likely to also sleep properly and turn up at the gym, the jar has arguably earned its money by a route the label never claimed.

Check for allergens, don’t exceed the stated dose, and mention it to your GP if you take prescription medicines. Then spend your money however you like. This is genuinely fine.

The injectable market is not fine, and the reason is specific.

The Rodent Problem

The logic behind injecting looks clean: if digestion destroys peptides, bypass digestion. Which is why there is a booming online trade in injectable peptides — BPC-157, TB-500, growth hormone secretagogues, melanotan for tanning.

Go and read the evidence base for any of them. Not the summary on the seller’s site — the actual studies. What you find is remarkably consistent: rats. Mice. Sometimes rabbits or dogs. Tendon healing in rats, gastric lesions in rats, muscle repair in mice. The work is often perfectly competent laboratory science. It is also, almost without exception, where the story stops.

That is the entire distinction between the vial and the pen from the pharmacy. Semaglutide was given to rodents too — that’s how drug development starts. The difference is that it then went through years of human trials, at escalating doses, with monitored volunteers, dropout rates, adverse events tabulated and published. BPC-157 has, for practical purposes, never done that. There is no phase III. There is no licensed dose. There is no human safety profile, because the studies that would produce one have not been run.

“Promising in rodents” is not a weaker version of “proven in humans”. It is a different category of statement, and the history of pharmacology is largely a graveyard of compounds that looked excellent in mice.

Why species differences aren’t a technicality

Rodents differ from humans in the enzymes that clear peptides, in receptor distribution, in immune response, in dose-to-body-mass scaling, and in lifespan — which is what makes long-term effects visible in the first place. A compound can be well tolerated in an animal that lives two years and cause problems in an organism expected to live eighty.

Growth-related compounds are the sharpest case. A signal that tells tissue to proliferate does not get to choose which tissue listens. In a rodent study lasting six weeks, that question never comes up. In a human taking it for two years, it is the whole question — and nobody has the data to answer it, in either direction.

What “research use only” is actually telling you

Almost every one of these products carries that line in small print, and it is not a formality. It is there because selling the compound for human use in the UK would be illegal.

Under the Human Medicines Regulations 2012, a substance sold to treat, prevent or alter a physiological function is a medicine, and supplying an unlicensed medicine is a criminal offence. There is no MHRA licence for BPC-157, TB-500 or the growth hormone secretagogues. The MHRA has issued repeated public warnings about melanotan specifically and has taken enforcement action against sellers. The “research use only” wording is what keeps a website one step from that liability — and it moves the entire risk onto you.

It also removes every protection you’d normally have without you noticing:

• Nobody guarantees the contents — independent testing of grey-market vials routinely finds wrong doses, contaminants, and sometimes a different compound entirely from the one on the label
• Nobody guarantees sterility, and there is no inspected facility behind it, because there is no licence to inspect
• Nobody has established a dose, so the protocols circulating online were written by users and by the people selling the vial
• Nobody is accountable, and there is no batch to recall if something goes wrong

Where “dangerous” stops being an abstraction

It is worth being precise here rather than dramatic, because the realistic harms are not exotic.

Injecting a non-sterile solution under your skin causes abscesses and cellulitis, and in a minority of cases progresses to bacteraemia and sepsis, which kills people every year in ordinary hospital medicine. An unknown compound introduced past your gut and straight into tissue can trigger anaphylaxis, and anaphylaxis is fatal without adrenaline within minutes. Contaminated product can carry endotoxin, which produces a severe systemic reaction on its own. None of that requires the peptide itself to be toxic. The delivery is enough.

Then add the part nobody can quantify: the unstudied long-term effect of a compound with no human data, taken at a dose somebody guessed.

And if it does go wrong, you’re sitting in A&E holding a substance that appears in no registry, with no verified ingredients and no verified dose. Clinicians are good, but they cannot treat what nobody can identify. That is a bad position to have argued yourself into over a tan, or a knee that clicks.

The Line That Actually Matters

Strip everything above down and it reduces to two sentences.

Oral peptides: your call. Probably won’t help, almost certainly won’t hurt, and if the routine has value to you then buy the jar with a clear conscience. This is a question about your budget, not your safety.

Injectable peptides: prescription and clinical supervision only. Not “a reputable supplier”. Not “a good protocol from someone experienced”. A prescriber who has seen your bloodwork, a licensed product with a batch number, a dose that exists in a datasheet, and someone accountable for the decision.

Worth knowing that the legitimate route is more accessible than most people assume. Weight-management prescriptions for tirzepatide have been rolling out through NHS primary care in England for patients meeting the eligibility criteria, alongside specialist weight-management services, and regulated private providers can prescribe after a proper consultation. Criteria change and they differ across England, Scotland, Wales and Northern Ireland, so check current NHS guidance rather than a forum. But once you compare it with a year of vials, the licensed option is often cheaper as well as safer.

Where the Money Is Actually Worth Going

Boring. Effective. Better documented than anything in this article’s supplement aisle.

Protein from food

Roughly 1.2 to 1.6 grams per kilogram of body weight if you train, or if you’re past forty. That is the same amino acid supply as the most expensive peptide protocol on the market, at a fraction of the cost, and it comes with the rest of the food attached.

Strength training

The only intervention that reliably instructs connective tissue to get stronger. Joints aren’t helped by being lubricated from the inside. They’re helped by the muscle holding them in position.

Sleep

Your largest natural pulse of growth hormone happens during deep sleep, free of charge, in an amount no secretagogue has demonstrated it can safely beat in humans.

Sunscreen and a retinoid

For skin, this pairing has an evidence base larger than the entire peptide skincare category combined. Retinol is available over the counter; tretinoin and adapalene need a prescription, and a GP or registered dermatology service can advise.

Vitamin D

The one supplement the NHS actually recommends for adults in the UK — 10 micrograms daily through autumn and winter. A few pounds a year. That advice exists because the evidence does.

And if the problem is genuinely medical

Weight that won’t move, a joint still stiff by mid-morning, fatigue a weekend doesn’t fix. Book the GP appointment. Sometimes the answer really is a peptide — with a dose, monitoring, and someone who has seen your blood tests. Treatable conditions get missed remarkably often when people decide in advance that the problem is discipline.

The Honest Summary

The digestion argument is not in serious dispute. Oral peptides are broken down into amino acids like any other protein, and no amount of marketing changes the enzymology. That part is settled.

What is genuinely unsettled is whether some of the injectable compounds would work if anyone properly tested them. BPC-157 may well turn out to have real effects in humans — the rodent data isn’t fabricated, and dismissing it outright would be as unscientific as selling it. The honest position is that we don’t know, and that the people selling it don’t know either. They are simply charging you for the uncertainty.

Two things follow.

The first: buying a peptide supplement isn’t gullibility. It’s a reasonable response to caring about your health in a market engineered to look like a laboratory. If that’s where you are, the jar is a harmless place to be.

The second: the needle is a different decision, and it deserves to be treated as one. Every peptide that has ever been proven to help a human being got there by being tested on human beings first, at a known dose, with someone watching. That process is not bureaucracy standing between you and results. It is the only reason we know which of these compounds are medicine and which are still, for now, an experiment on rats — with you volunteering to be the next data point, unrecorded.

---

This article is for general information and is not medical advice. Speak to your GP or a pharmacist before starting or stopping any supplement or medicine, and never inject a substance that has not been prescribed to you. Suspected side effects from a medicine can be reported through the MHRA Yellow Card scheme.